Neal Walker, President and CEO at Aclaris Therapeutics, Inc. (ACRS), sold 70,000 shares at $15.18 ($1.1M) on 2022-04-25, disclosed to the SEC on 2022-04-25.
Open-market sale of $1.1M ACRS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.24 | 25,000 | $381K | 35.9% |
| 2 | $15.04 | 25,000 | $376K | 35.5% |
| 3 | $15.18 | 20,000 | $304K | 28.6% |
| Total | $15.15 avg | 70,000 | $1.1M | 100% |
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |
| ACRS | SELL | 2022-02-11 | $46K | — | Filing → |